These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30578945)

  • 1. Inflammatory profiles of severe treatment-resistant depression.
    Strawbridge R; Hodsoll J; Powell TR; Hotopf M; Hatch SL; Breen G; Cleare AJ
    J Affect Disord; 2019 Mar; 246():42-51. PubMed ID: 30578945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review.
    Yang C; Wardenaar KJ; Bosker FJ; Li J; Schoevers RA
    J Affect Disord; 2019 Oct; 257():640-649. PubMed ID: 31357161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.
    Kiraly DD; Horn SR; Van Dam NT; Costi S; Schwartz J; Kim-Schulze S; Patel M; Hodes GE; Russo SJ; Merad M; Iosifescu DV; Charney DS; Murrough JW
    Transl Psychiatry; 2017 Mar; 7(3):e1065. PubMed ID: 28323284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study.
    Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP
    Psychiatry Res; 2018 Nov; 269():207-211. PubMed ID: 30153598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated tumor necrosis factor-alpha receptor subtype 1 and the association with abnormal brain function in treatment-resistant depression.
    Huang MH; Chen MH; Tu PC; Bai YM; Su TP; Yang BH; Liu RS; Li CT
    J Affect Disord; 2018 Aug; 235():250-256. PubMed ID: 29660639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular serum signature of treatment resistant depression.
    Ruland T; Chan MK; Stocki P; Grosse L; Rothermundt M; Cooper JD; Arolt V; Bahn S
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):3051-9. PubMed ID: 27325393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method.
    Peeters FP; Ruhe HG; Wichers M; Abidi L; Kaub K; van der Lande HJ; Spijker J; Huibers MJ; Schene AH
    J Affect Disord; 2016 Nov; 205():365-371. PubMed ID: 27568174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment-resistant depression and Axis II comorbidity.
    Petersen T; Hughes M; Papakostas GI; Kant A; Fava M; Rosenbaum JF; Nierenberg AA
    Psychother Psychosom; 2002; 71(5):269-74. PubMed ID: 12207107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.
    Vinberg M; Weikop P; Olsen NV; Kessing LV; Miskowiak K
    Brain Behav Immun; 2016 Oct; 57():53-57. PubMed ID: 27181179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term symptomatic and functional outcome following an intensive inpatient multidisciplinary intervention for treatment-resistant affective disorders.
    Wooderson SC; Fekadu A; Markopoulou K; Rane LJ; Poon L; Juruena MF; Strawbridge R; Cleare AJ
    J Affect Disord; 2014 Sep; 166():334-42. PubMed ID: 25012450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Machine Learning help us in dealing with treatment resistant depression? A review.
    Pigoni A; Delvecchio G; Madonna D; Bressi C; Soares J; Brambilla P
    J Affect Disord; 2019 Dec; 259():21-26. PubMed ID: 31437696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients.
    Maffioletti E; Bocchio-Chiavetto L; Perusi G; Carvalho Silva R; Sacco C; Bazzanella R; Zampieri E; Bortolomasi M; Gennarelli M; Minelli A
    Eur J Psychotraumatol; 2021; 12(1):1987655. PubMed ID: 35070159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
    Wu Z; Chen J; Yuan C; Hong W; Peng D; Zhang C; Cao L; Fang Y
    J Affect Disord; 2013 Sep; 150(3):834-9. PubMed ID: 23570952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
    Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
    J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding treatment-resistant depression using "omics" techniques: A systematic review.
    Amasi-Hartoonian N; Pariante CM; Cattaneo A; Sforzini L
    J Affect Disord; 2022 Dec; 318():423-455. PubMed ID: 36103934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age as a moderating factor of treatment resistance in depression.
    Kautzky A; Bartova L; Fugger G; Dold M; Souery D; Montgomery S; Zohar J; Mendlewicz J; Fabbri C; Serretti A; Rujescu D; Kasper S
    Eur Psychiatry; 2023 Apr; 66(1):e35. PubMed ID: 37078509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations.
    Yamamura T; Okamoto Y; Okada G; Takaishi Y; Takamura M; Mantani A; Kurata A; Otagaki Y; Yamashita H; Yamawaki S
    Transl Psychiatry; 2016 Mar; 6(3):e754. PubMed ID: 26954981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden.
    Reutfors J; Andersson TM; Brenner P; Brandt L; DiBernardo A; Li G; Hägg D; Wingård L; Bodén R
    J Affect Disord; 2018 Oct; 238():674-679. PubMed ID: 29966932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.